Search
News
Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Immune checkpoint inhibitors have demonstrated limited efficacy in treating prostate cancer. Efforts to improve outcomes with combination therapies have mostly failed to demonstrate improvements compared to other types of cancer.
News
Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future Therapies
Video
Strategies for Head and Neck Cancer: What to Look, Feel and Listen For
UCSF specialist Chase Heaton, MD, presents a guide to identifying head and neck cancers, including steps, tools and tips for a comprehensive exam; alarm-bell statements from your patients; and the one assumption you want to make about any neck lump.
News
UCSF-Led Study Confirms Some Cancer Immunotherapies May Lead to Myocarditis and Other Potentially Serious Arrhythmias
Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis.
News
Powerful New Mini Microscopic Will Enable Precision Cancer Surgery
UCSF’s Mekhail Anwar wins an up to $15 million award from ARPA-H to develop a next-generation miniature scanner powerful enough to detect individual cancer cells during surgery.
Video
Update on Liver Lesions: What Works in Managing HCC
Based on clear metrics, transplant hepatologist Neil Mehta, MD, presents diagnostic criteria for hepatocellular carcinoma, then shows how UCSF’s HCC team reaches decisions on treatment for individual cases – with plans ranging from resection or ablation to downstaging drugs and transplantation.
Document
Melanoma and Skin Cancer Program
Highly specialized care for patients with melanoma, Merkel Cell and other skin cancers
Video
Making Sense of MGUS: How to Detect Plasma Cell Disorders and Assess Associated Risks
Affecting up to 5% of the U.S. population (and increasingly common with age), monoclonal gammopathy of undetermined significance (MGUS) raises the risk of multiple myeloma, but – as its full name suggests – it can be hard to say by how much.
News
Post-Pandemic Cancer Care Delivery: Recovery or Redesign?
The COVID-19 pandemic has prompted major changes in the way clinicians deliver care, and nowhere have these changes been more urgent than in the field of oncology.
News
Renal Cell Carcinoma Research Sheds New Light on Advanced Disease
In a recent study, UCSF researchers found that renal cell carcinoma (RCC)with venous tumor thrombus(VTT) does not always signify metastatic disease with poor prognosis. These findings provide insight into the development of advanced RCC and may help to better inform surveillance regimens and treatment decisions and, ultimately, improve clinical outcomes.
Video
Navigating the Maze of Breast Cancer Guidelines: Efficient Paths to Personalized Screening
To help PCPs address patients’ breast cancer screening concerns, surgeon Shoko Emily Abe, MD, FACS, breaks down the multitude of screening directives and modalities, with a focus on the needs of those at average risk and those with dense breast tissue.
Video
Mammography 101
Bonnie Joe, MD explains the differences between screening and diagnostic mammography, shows evidence for screening, answers common questions about radiation risk and false positives and discusses digital breast tomosynthesis, also known as 3D mammography.
News
Drug Turns Cancer Gene Into "Eat Me" Flag for Immune System
UCSF-led study shows promising pre-clinical results in killing cancer cells resistant to current KRAS-targeted treatments.
Video
The Human Microbiome and Breast Cancer
Immunologist Michael Campbell and breast cancer surgeon Laura Esserman speak at the April 2017 Bay Area Breast Cancer Forum about the human biome, how it’s being studied and how it relates to breast cancer prevention and treatment.
News
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the world came together for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest developments in cancer care, research, technology and education.
News
Advancing Precision Medicine for Neuro-Oncology Patients: Q&A with David Solomon, MD, PhD
UC San Francisco neuropathologist and molecular neuro-oncologist David Solomon, MD, PhD has reached a unique and impressive milestone: the publication of his team's 50th neuro-oncology research study stemming from the UCSF500 Cancer Gene Panel, a molecular diagnostic test that identifies genetic changes in the DNA of a patient's cancer.
Document
2019-20 Referral Services Guide
UCSF Health is recognized throughout the world for innovative treatments, advanced technology, collaboration among clinicians and scientists, and a highly compassionate team of patient care providers.
Video
Approaches to Hematologic Cancers
Jeffrey Wolf, MD, director of the Myeloma Program at UCSF Health, discusses the traditional approaches to hematologic cancers.
News
UCSF Deploys Innovative Data System to Integrate Research and Care
UC San Francisco (UCSF), in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA) has developed the OneSource system to seamlessly integrate clinical care and research data.
Video
Hope on the Horizon: Specialists Reveal New Approaches to Deadly Malignancies
Here’s an exciting look at recent improvements in our understanding and management of certain malignancies normally associated with a poor prognosis.
News
Pancreatic Cancer Patient Exceeds Life Expectancy After Complex Whipple Procedure at UCSF
A team of UCSF surgeons devised a successful reconstruction approach during a complex Whipple procedure in a 69-year-old man with locally advanced pancreatic adenocarcinoma.
News
UCSF Prostate Cancer Specialist Inducted into Annual Class of “Giants of Cancer Care”
Eric Small, MD, has been announced as one of the winners of the 10th annual Giants of Cancer Care® awards.
News
Prioritizing Organ Preservation for Rectal Cancer Patients
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required.
Video
Cancer Immunotherapy: Promise and Pitfalls
Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.
